HAPPEL DAVID (President & CEO) sold 8.0% of their position (64.05K shares) of SAGIMET BIOSCIENCES INC. on the open market
Open‑market sale worth $497.1K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 7/22/2026ACC: 0001193125-26-312397
DirectorOfficer· President & CEO
Since Feb 2026
-64.05K
Net shares
Net seller
$497.1K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
64.05K disposed
Non-Derivative Transactions1
Series A Common Stock
Direct
Shares
−64.05K
Price / share
$7.76
Trade value
$497.07K
% of position
8.0%
7/20/2026
805.62K→741.57K
Total
Net shares
−64.05K
Net value
-$497.07K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Series A Common Stock Direct | 7/20/2026 | S · Sale | −64.05K | $7.76 | $497.07K | 8.0% | 805.62K | 741.57K |
| Total | −64.05K | -$497.07K | ||||||
Derivative Transactions0
No derivative transactions reported